Dosage ; 1200mg daily in 2 divided doses. Range 0.9 - 1.5g/day.
Combinations ; - see below
| Brand Name | Manufacturer Name | Distributor | Drug Strength | Packaging | Formulation | Formulation Strength | Price |
|---|---|---|---|---|---|---|---|
| Ltd. | Ltd | 450mg/50mg | 30 | Tablet | per tablet | KES | |
| Ltd | (K) Ltd. | 450mg/50mg | 30 | Tablet | per tablet | KES |
| Gemfibrozil More info | |
|---|---|
| Mode Of Action | Drugs that decrease serum triglycerides and very low-density lipoprotein (VLDL) cholesterol and increase high-density lipoprotein (HDL) |
| Drug Indication | Primary hyperlipidaemia type IIa, IIb, III, IV and V; secondary hyperlipidaemia not responsive to other measures. |
| Precautions | Oestrogen therapy; monitor therapy (withdraw drug after 3 months if no adequate response); perform periodic blood counts in the first 12 months of administration; if used with cholestyramine there should be 2 hours period between the two medicines. |
| Contra-Indications | Renal and hepatic impairment; pregnancy and lactation; primary biliary cirrhosis; gall bladder disease. |
| Dosage | 1200mg daily in 2 divided doses. Range 0.9 - 1.5g/day. |
| Pregnancy Category | Category B3 |
| Pregnancy Category Description | Drugs which have been taken by only a small number of pregnant women and women of child-bearing age with no any established rise in the frequency of malformations or other direct or indirect detrimental effects on the foetus having been noted. Studies in animals show evidence of an increased occurrence of foetal damage, the significance of which is uncertain in human |
| Drug Category | DRUGS ACTI NG ON THE CARDIO-VASCULAR SYSTEM |
| Drug Sub-Category | Drugs for dyslipidaemia |